|
Volumn 69, Issue 4, 2014, Pages 383-384
|
Prenatal origins of bronchiolitis: Protective effect of optimised asthma management during pregnancy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
NITRIC OXIDE;
ARTICLE;
ASTHMA;
BRONCHIOLITIS;
COHORT ANALYSIS;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DISEASE EXACERBATION;
DOUBLE BLIND PROCEDURE;
FEMALE;
FOLLOW UP;
FRACTION OF EXHALED NITRIC OXIDE;
GESTATIONAL AGE;
HUMAN;
INFANCY;
INFANT;
MAJOR CLINICAL STUDY;
MALE;
MATERNAL CARE;
MATERNAL SMOKING;
NEWBORN;
OUTCOME ASSESSMENT;
PREGNANCY;
PREGNANT WOMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT PARAMETERS;
RISK REDUCTION;
SEX DIFFERENCE;
WHEEZING;
ASTHMA;
ASTHMA;
BREATH TESTS;
BRONCHIOLITIS;
BRONCHODILATOR AGENTS;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFANT;
INFANT, NEWBORN;
LOGISTIC MODELS;
MALE;
NITRIC OXIDE;
PREGNANCY;
PREGNANCY COMPLICATIONS;
PRENATAL EXPOSURE DELAYED EFFECTS;
PREVALENCE;
QUESTIONNAIRES;
RECURRENCE;
|
EID: 84895924586
PISSN: 00406376
EISSN: 14683296
Source Type: Journal
DOI: 10.1136/thoraxjnl-2013-203388 Document Type: Article |
Times cited : (42)
|
References (5)
|